Trials / Recruiting
RecruitingNCT07185594
A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery
A Phase Ⅱ/Ⅲ Study to Evaluate the Efficacy and Safety of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II/III, multi-center, randomized, double-blind, comparator-controlled study to evaluate the efficacy and safety of HRS-2129 for postoperative pain management in abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-2129 Tablets | HRS-2129 tablets. |
| DRUG | Blank Preparation. | Blank preparation. |
| DRUG | Tramadol Hydrochloride SR Tablets | Tramadol Hydrochloride SR tablets. |
Timeline
- Start date
- 2025-10-24
- Primary completion
- 2025-12-01
- Completion
- 2026-01-01
- First posted
- 2025-09-22
- Last updated
- 2025-11-17
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07185594. Inclusion in this directory is not an endorsement.